Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

NCT01355289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopenia

Interventions

DRUG: Avatrombopag
DRUG: Placebo
DRUG: Pegylated interferon (PEG-IFN)
DRUG: Telaprevir
DRUG: Ribavirin

Sponsor

Eisai Inc.